Abstract
To the Editor:
The American Medical Association (AMA) has dedicated substantial resources to an ongoing multiyear campaign promoting the Physician Data Restriction Program (PDRP), which gives all physicians the choice to designate their prescription data as off limits to pharmaceutical detailers. In their article regarding restrictions on the use of prescribing data for drug promotion, Mello and Messing (Sept. 29 issue)
1
call into question the AMA's commitment on the basis of unfounded speculation that ignores the facts.
Despite national publicity for the PDRP, physician awareness of the program has little effect on enrollment rates. Enrollment in the program is free, . . .